MGLN Insider Trading Activity and SEC Form 4 Filings
MGLN insider trading summary
No open-market insider purchases or sales of Magellan Health Inc (MGLN) have been reported on SEC Form 4 in the past 12 months.
Latest MGLN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 9, 2020 | Mostafa Kamal | CEO, Magellan Rx Management | Sell | $223K (2,793 @ $79.69) |
| Nov 16, 2020 | Mostafa Kamal | CEO, Magellan Rx Management | Sell | $658K (7,603 @ $86.57) |
| Nov 13, 2020 | Mostafa Kamal | CEO, Magellan Rx Management | Sell | $1.1M (13,282 @ $83.82) |
| Nov 10, 2020 | Mostafa Kamal | CEO, Magellan Rx Management | Sell | $489K (6,000 @ $81.57) |
| Nov 5, 2020 | Mostafa Kamal | CEO, Magellan Rx Management | Sell | $287K (3,589 @ $79.87) |
| Nov 4, 2020 | Jeffrey N West | SVP & Controller | Sell | $11K (139 @ $80.00) |
| Nov 4, 2020 | Mostafa Kamal | CEO, Magellan Rx Management | Sell | $274K (3,434 @ $79.89) |
| Nov 4, 2020 | Jeffrey N West | SVP & Controller | Sell | $198K (2,481 @ $80.00) |
| Oct 16, 2020 | Mostafa Kamal | CEO, Magellan Rx Management | Sell | $15K (183 @ $79.87) |
| Oct 7, 2020 | Jeffrey N West | SVP & Controller | Sell | $118K (1,500 @ $78.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.